SCR-LIP-000745 · Claim · machine-readable JSON →
Evidence on DXA and other imaging tools for lipedema remains limited, with small heterogeneous samples and poorly reported reliability.
General proposition consolidated from 2 earlier single-paper claims; each study's own result is shown as its finding.
Claim at a glance
- Type
- clinical association
- Knowledge state
- Emerging
- Evidence certainty
- moderate (GRADE)
- Evidence
- 2 source(s)
- Answers
- 1 question(s)
- Dates
- 2026-11-20 → 2026-11-20
Structured evidence, machine-compiled — not a verdict.
Evidence over time
Evidence (2)
- Diagnostic imaging in lipedema: A systematic review — van la Parra et al. (2024) ✓ verified — consistent · review · 2024 · reading confidence: high
“The diagnostic performance of currently available imaging modalities for assessing lipedema is limited. Prospective studies are needed to evaluate and compare the diagnostic performance of each imaging modality.”
Systematic review of 32 studies (1154 patients) lists DXA cutoffs (leg fat/BMI >=0.46, leg fat/total fat >=0.384) among imaging methods, but overall diagnostic performance was limited.
Systematic review evaluating diagnostic imaging methods for lipedema; relevant to diagnostic criteria/reliability, refining by reporting that imaging-based diagnostic performance is currently limited rather than well-established. - Assessment Tools to Quantify the Physical Aspects of Lipedema: A Systematic Review — Eason et al. (2025) ✓ verified — consistent · review · 2025 · reading confidence: high
“Reporte limitado de clinimetria, derivado de pequenas coortes em populações heterogêneas, impactou a capacidade de recomendar ferramentas para prática clínica e pesquisa. Investigações adicionais são necessárias para estabelecer validade e reliability de ferramentas de medição e imagem”
Review of 13 quantification tools: heterogeneous, poorly documented protocols and rarely reported clinimetric reliability, from small heterogeneous cohorts, preventing recommendations.
Systematic review focused on objective measurement/imaging tools and their reliability/diagnostic performance in lipedema, which addresses the reliability aspect of the question, though it concerns quantification tools rather than clinical
Context (PECO)
Answers these questions
Gaps & caveats
Change log
- 2026-11-20 — created_by_consolidation · general proposition consolidated from SQ-LIP-000031